Authors: Sogol Sedighi, Ting Liu, Brian O’Rourke, D Foster
Published: 2024-10-09
DOI: 10.1161/res.135.suppl_1.tu055
Source: Full article
Introduction: The p38 mitogen-activated protein kinase (p38 MAPK), activated by stress, plays a role in cardiac hypertrophy and heart failure (HF). The precise mechanism of action of p38 MAPK remains unclear, which could explain the mixed outcomes in P38 inhibitor trials. Here, we examine the impact of p38 MAPK inhibition on cardiac function and the proteome/phosphoproteome of the failing heart.